470 related articles for article (PubMed ID: 19221985)
21. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
[TBL] [Abstract][Full Text] [Related]
22. Institutional review board guidance on pediatric research: missed opportunities.
Wolf LE; Zandecki J; Lo B
J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
[TBL] [Abstract][Full Text] [Related]
23. Comparison of German and American law concerning clinical trials.
Deutsch E
Pediatr Pharmacol (New York); 1983; 3(3-4):353-9. PubMed ID: 6677881
[TBL] [Abstract][Full Text] [Related]
24. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
Rossion I
Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
[TBL] [Abstract][Full Text] [Related]
25. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
Dilts DM; Sandler AB
J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Russ H; Busta S; Jost B; Bethke TD
Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
[TBL] [Abstract][Full Text] [Related]
27. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
Georgias C; Grunow A; Olderog M; May A; Paulus U
Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
[TBL] [Abstract][Full Text] [Related]
28. Clinical trials in New Zealand--treading water in the knowledge wave?
Jull A; Wills M; Scoggins B; Rodgers A
N Z Med J; 2005 Aug; 118(1221):U1638. PubMed ID: 16138176
[TBL] [Abstract][Full Text] [Related]
29. Research with minors in Germany.
Buchner B; Hart D
Eur J Health Law; 2008 Jul; 15(2):127-34. PubMed ID: 18988591
[TBL] [Abstract][Full Text] [Related]
30. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
[TBL] [Abstract][Full Text] [Related]
31. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
Altavilla A; Giaquinto C; Ceci A
J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
[TBL] [Abstract][Full Text] [Related]
32. The development of good clinical practice in the EEC and in Germany.
Anhalt E
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
[TBL] [Abstract][Full Text] [Related]
33. Legal requirements for drug testing in children in Germany.
Hasskarl H
Pediatr Pharmacol (New York); 1983; 3(3-4):361-6. PubMed ID: 6677882
[TBL] [Abstract][Full Text] [Related]
34. Case study: agency says institutional review board (IRB) failed to warn subjects of significant problems.
Maloney DM
Hum Res Rep; 2006 Mar; 21(3):6-7. PubMed ID: 16789303
[No Abstract] [Full Text] [Related]
35. [Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law].
Benninger-Döring G; Boos J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jul; 49(7):675-80. PubMed ID: 16763801
[TBL] [Abstract][Full Text] [Related]
36. Rejuvenating a foundering institutional review board: one institution's story.
De Ville K; Hassler G; Lewis MJ
Acad Med; 2007 Jan; 82(1):11-7. PubMed ID: 17198283
[TBL] [Abstract][Full Text] [Related]
37. [Application for academic multicenter studies at German ethical review boards].
Gökbuget N; Naumann R;
Onkologie; 2013; 36 Suppl 2():29-35. PubMed ID: 23549034
[TBL] [Abstract][Full Text] [Related]
38. Case study: research subject says institutional review board (IRB) would not answer her questions.
Maloney DM
Hum Res Rep; 2006 Feb; 21(2):7. PubMed ID: 16789309
[No Abstract] [Full Text] [Related]
39. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
40. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
